Stature is a key indicator of pediatric health, yet the molecular and metabolic architecture governing childhood growth remains incompletely defined. We conduct genome-wide association analyses of stature from birth to childhood (574,580 measurements; 72,704 Norwegian children) and integrate UK Biobank data (age 10 and adulthood). We uncover life-stage shifts in the genetics of stature, identifying previously not identified childhood-specific effects including variants near GLP1R with BMI-independent effects, and reveal three temporal clusters - Infancy and Childhood clusters enriched for endocrine and metabolic pathways, and a Lifetime growth cluster enriched for skeletal biology. Proteome analysis reveals that prepubertal height is associated with widespread changes in the circulation, identifying 106 height-associated proteins and linking IGF1, IGF2, and IGFBP3 levels to childhood-height polygenic scores. Mendelian randomization shows that reduced fetal growth and taller prepubertal height increase type 2 diabetes risk, independent of adult stature. These findings uncover developmental stage-specific genetic and proteomic influences on child-growth and links to adult metabolic health. Childhood growth reflects complex genetic and biological processes, but their developmental timing is not fully understood. Here, the authors identify stage‑specific genetic and proteomic influences on growth from infancy through childhood, and reveal links between early growth patterns and later type 2 diabetes risk.